Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Tong Ren Tang Technologies Co ( (HK:1666) ) has provided an update.
Tong Ren Tang Technologies Co. Ltd. has called an extraordinary general meeting for 6 February 2026 in Beijing to seek shareholder approval for the appointment of Mr. Siu, Paul Yu Hay as an independent non-executive director for the ninth session of its board, including the proposed remuneration and authorisation for a service contract. The meeting notice also sets out eligibility, proxy, and registration arrangements for both H share and domestic shareholders, underscoring the company’s ongoing board renewal and governance processes aimed at maintaining robust oversight and aligning with Hong Kong listing requirements.
The most recent analyst rating on (HK:1666) stock is a Hold with a HK$4.50 price target. To see the full list of analyst forecasts on Tong Ren Tang Technologies Co stock, see the HK:1666 Stock Forecast page.
More about Tong Ren Tang Technologies Co
Tong Ren Tang Technologies Co. Ltd. is a joint stock company incorporated in the People’s Republic of China and listed in Hong Kong, operating in the pharmaceutical and traditional Chinese medicine sector. The company is governed by a board comprising executive, non-executive, independent non-executive and employee directors, reflecting a typical listed company governance structure focused on both domestic and international investors through H shares and domestic shares.
Average Trading Volume: 1,185,293
Technical Sentiment Signal: Sell
Current Market Cap: HK$5.76B
Learn more about 1666 stock on TipRanks’ Stock Analysis page.